London Urology Specialists
Brings together the expertise of eight highly regarded consultant urological surgeons.
Our aim is to deliver a high quality service to you through a combination of a thorough, well recognised, proven approach combined with the latest diagnostic and surgical techniques.
At King Edward VII’s Medical Centre, our main clinic, we have a dedicated on-site outpatient facility with impressive diagnostic facilities. This ensures we are able to provide convenient appointments and quick access to tests and reports.
As a patient, you can have peace of mind, knowing that you can expect minimal waiting times for test results, imaging and surgery. We understand that our patients expect and demand first rate care and we aim to be second to none in providing this.
Mr Daron Smith
MA(Cantab) BMBCh(Oxon) MD(Lon) FRCS(Urol)Mr Daron Smith (Richard Daron Smith) qualified with a first-class honours degree in Medical Sciences from Gonville and Caius College, Cambridge in 1991. He studied clinical medicine at the John Radcliffe Hospital, where he was a graduate student at New College, Oxford, qualifying with a BMBCh in 1994. He completed his MD at Imperial College, London, supported by a prestigious grant from the British Urological Foundation before embarking on specialist training in Urology on the West London training scheme. He underwent subspecialist training in EndoUrology at St Mary's Hospital, Guy's Hospital and at the Institute of Urology at University College Hospital.Mr Smith was initially appointed as a Consultant Urological Surgeon to Imperial NHS trust in 2007, and moved to the Stone and EndoUrology unit at the Institute of Urology, UCH in 2009. He is a keen teacher, and has lectured on aspects of urolithiasis for the Scientific Basis of Urology Course, the FRCS(Urol) revision course and the national “Modern Management of Stone Disease” course, as well as involvement as faculty at international meetings. He is the consulting editor (stone disease) for the BJUI (British Journal of Urology International) and the vice-chairman of the Endourology Section of BAUS (British Association of Urological Surgeons).
Areas of Urological Practice
Richard Daron Smith is a consultant urological surgeon with a sub-specialist practice in endourology, and stone disease in particular.
His research interest include Imaging Characteristics of Acute Ureteric Colic; Stone biochemistry and Hounsfield Unit correlation. Prevalence and relevance of Randall's Plaques in stone disease.
References
The British Urology Researchers in Surgical Training (BURST) Research Collaborative: an alternative research model for carrying out large scale multi-centre urological studies. Kasivisvanathan V, Ahmed H, Cashman S, Challacombe B, Emberton M, Gao C, Lamb BW, Nambiar A, Pickard R, Shah TT, Smith D. BJU Int. 2017 Oct 3. doi: 10.1111/bju.14040. [Epub ahead of print]
British Association of Urological Surgeons standards for management of acute ureteric colic Alexios Tsiotras, R Daron Smith, Ian Pearce, Kieran O’Flynn, Oliver Wiseman Journal of Clinical Urology, Published 6 Nov 2017
Schistosomiasis-A Disobedient Ureter, a Disobedient Diagnosis. Pal PO, Smith RD, Allen S, Ratynska M, Edwards S, Gothard P, Logan S. J Endourol Case Rep. 2017 Aug 1;3(1):114-118.
Pre-stenting and the risk of postoperative sepsis: a shorter dwell time is better. Smith D. BJU Int. 2017 Jul;120(1):7-8.
Ultrasonography vs computed tomography for stone size. Smith D, Patel U. BJU Int. 2017 Mar;119(3):361-362.
Advances in urology 2015–2016 Simon Brewster, Suzanne Biers, Ben Challacombe, Jo Cresswell, Andrew Sinclair, Daron Smith Journal of Clinical Urology, vol. 10, 1: pp. 39-48. Published December 1, 2016.
Urolithiasis in pregnancy Marios Hadjipavlou, Ali Tasleem, Francois Dos Santos, Daron Smith, Seshadri Sriprasad Journal of Clinical Urology, vol. 10, 2: pp. 93-104. Published November 18, 2016.
Biochemical composition of urolithiasis from stone dust - a matched-pair analysis. Ray ER, Rumsby G, Smith RD. BJU Int. 2016 Oct;118(4):618-24.
Early multicentre experience of ultra-mini percutaneous nephrolithotomy in the UK Ben Pullar, Eric Havranek, Tony J R Blacker, Sam N Datta, Bhaskar Somani, Seshadri Sriprasad, Hari Ratan, Sharon Scriven, Simon Choong, R Daron Smith, Simon Mackie, Graham Watson, Oliver J Wiseman Journal of Clinical Urology, vol. 10, 2: pp. 124-128. Published July 8, 2016
Advances in urology 2014–2015 Jo Cresswell, Marc Laniado, Andrew Sinclair, Daron Smith, Suzie Venn, Simon Williams, Simon Brewster Journal of Clinical Urology, vol. 9, 4: pp. 223-229. Published April 5, 2016
Mini, ultra, micro' - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques. Wright A, Rukin N, Smith D, De la Rosette J, Somani BK. Ther Adv Urol. 2016 Apr;8(2):142-6.
Contemporary Management of Stone Disease: The New EAU Urolithiasis Guidelines for 2015. Bultitude M, Smith D, Thomas K. Eur Urol. 2016 Mar;69(3):483-4.
Tips and tricks of ureteroscopy: consensus statement. Part II. Advanced ureteroscopy. Rukin NJ, Somani BK, Patterson J, Grey BR, Finch W, McClinton S, Parys B, Young G, Syed H, Myatt A, Samsudin A, Inglis JA, Smith D. Cent European J Urol. 2016;69(1):98-104.
Tips and tricks of ureteroscopy: consensus statement Part I. Basic ureteroscopy. Rukin NJ, Somani BK, Patterson J, Grey BR, Finch W, McClinton S, Parys B, Young G, Syed H, Myatt A, Samsudin A, Inglis JA, Smith D. Cent European J Urol. 2015;68(4):439-46
Would You Want to Be the Patient? "Live Surgical Broadcast" or "As-Live Unedited Surgical Broadcast". Finch W, Masood J, Buchholz N, Turney BW, Smith D, Wiseman O. J Endourol. 2015 Mar 16.
Size (and shape) is important and sometimes strings should be attached, but quality matters most where the BJUI and stone disease are concerned … Daron Smith BJU International, Volume 113, Issue 4, April 2014, Pages: 511–512 The dilemma of post-ureteroscopy stenting. Hughes B, Wiseman OJ, Thompson T, Masood J, Smith RD, McIlhenny C, Irving S, Dasgupta R, Bultitude MF. BJU Int. 2014 Feb;113(2):184-5
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis Daron Smith and Chris Laing BJU International Volume 111, Issue 4, April 2013, Pages: 529–530
Acute Loin Pain: Stones, Scopes, Shocks and Stents Daron Smith British Journal of Medical and Surgical Urology, vol. 5,3: pp. 150-158. Published May 1, 2012
Bones and stones Daron Smith and Chris Laing BJU International, Volume 108, Issue 11, December 2011, Page: 1908 Causes of renal forniceal rupture Daron Smith BJU International Volume 108, Issue 11, December 2011, Page: 1912
Prospective comparative study of miniperc and standard pnl for treatment of 1 to 2 cm size renal stone Daron Smith BJU International, Volume 108, Issue 6, September 2011, Pages: 899–900
Transurethral resection of the prostate revisited and updated. Daron Smith and Anup Patel Curr Opin Urol. 2011 Jan;21(1):36-41.
Percutaneous urinary drainage and ureteric stenting in malignant disease. Allen DJ, Longhorn SE, Philp T, Smith RD, Choong S. Clin Oncol (R Coll Radiol). 2010 Nov;22(9):733-9.
Recent advances in management of ureteral calculi. Smith RD, Shah M, Patel A. F1000 Medicine Reports 2009, 1:53 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948312/
Impact of flexible ureterorenoscopy in current management of nephrolithiasis. Smith RD, Patel A. Curr Opin Urol. 2007 Mar;17(2):114-9.
Bipolar electrosurgery for benign prostatic hyperplasia: transurethral electrovaporization and resection of the prostate. Smith D, Khoubehi B, Patel A. Curr Opin Urol. 2005 Mar;15(2):95-100.
Antenatal diagnostic aspects of unilateral multicystic kidney dysplasia--sensitivity, specificity, predictive values, differential diagnoses, associated malformations and consequences. Eckoldt F, Woderich R, Smith RD, Heling KS. Fetal Diagn Ther. 2004 Mar-Apr;19(2):163-9.
Exclusive amplification of cDNA template (EXACT) RT-PCR to avoid amplifying contaminating genomic pseudogenes. Smith RD, Ogden CW, Penny MA. Biotechniques. 2001 Oct;31(4):776-8, 780, 782.
Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. Khoubehi B, Kessling AM, Adshead JM, Smith GL, Smith RD, Ogden CW. J Urol. 2001 Jun;165(6 Pt 1):2115-20.
Survivin gene expression and prognosis in recurrent colorectal cancer. Miller M, Smith D, Windsor A, Kessling A. Gut. 2001 Jan;48(1):137-8.
Xanthogranulomatous pyelonephritis and renal malignancy: unusual fellows in the renal bed. Smith RD, Khoubehi B, Chandra A, Glass JM, Mee AD. BJU Int. 2000 Sep;86(4):558-9.
Trigger wrist and flexor tenosynovitis. Smith RD, O'Leary ST, McCullough CJ. J Hand Surg Br. 1998 Dec;23(6):813-4.
Mr Bijan Khoubehi
BSc, MB, BS, MD, FRCS (Urol)Bijan Khoubehi is a Consultant Urological Surgeon at Chelsea and Westminster Hospital NHS Foundation Trust. He qualified at Charing Cross and Westminster Medical School (now Imperial College London) achieving his MB BS with Honours in Surgery in 1994. Following basic surgical training, he became a Fellow of the Royal College of Surgeons in 1998. He undertook a research project looking at the role of development genes, specifically PAX2, in prostate cancer. This ground-breaking research was the basis of his higher degree (MD) from the University of London in 2001. He was awarded the prestigious Research Fellowship by The Royal College of Surgeons of England for his research.
Bijan carried out his urological training in London. Having completed his general urological training, he undertook two fellowship years in Urological Oncology. He was awarded a British Urological Foundation scholarship for Robotic Surgery. He has been performing robotic radical prostatectomies since 2007 and was one of the first surgeon to master this technique in UK.
He treats patients with general urological conditions and has a special interest in uro-oncology including nerve sparing Robotic radical prostatectomy, robotic and laparoscopic renal surgery for malignant and benign conditions as well as radical cystoprostatectomy and ileo-orthotopic bladder substitution. He has published widely in peered reviewed journals.
He is a high-volume surgeon for robotic prostatectomy and renal surgery. For robotic radical prostatectomy, his results for cancer margins, continence and potency are equivalent to the best-published data in the world.
Bijan Khoubehi is the lead clinician for urology at his NHS practice and has a busy urology practice performing robotic, laparoscopic and open surgery for urological cancer. Bijan prides himself on offering a completely honest, ethical and genuinely caring service, which is totally patient centred. He has had articles published about his work in national newspapers including Daily Mail and Mirror. He has published widely in peered reviewed journals. Bijan lives in London with his wife and two children.
Areas of Urological Practice
He treats patients with general urological conditions and has a special interest in uro-oncology including nerve sparing Robotic radical prostatectomy, robotic and laparoscopic renal surgery for malignant and benign conditions as well as radical cystoprostatectomy and ileo-orthotopic bladder substitution. He has published widely in peered reviewed journals.
He is a high-volume surgeon for robotic prostatectomy and renal surgery. For robotic radical prostatectomy, his results for cancer margins, continence and potency are equivalent to the best-published data in the world.
Bijan Khoubehi is the lead clinician for urology at his NHS practice and has a busy urology practice performing robotic, laparoscopic and open surgery for urological cancer. Bijan prides himself on offering a completely honest, ethical and genuinely caring service, which is totally patient centred. He has had articles published about his work in national newspapers including Daily Mail and Mirror. He has published widely in peered reviewed journals. Bijan lives in London with his wife and two children.
References
He treats patients with general urological conditions and has a special interest in uro-oncology including nerve sparing Robotic radical prostatectomy, robotic and laparoscopic renal surgery for malignant and benign conditions as well as radical cystoprostatectomy and ileo-orthotopic bladder substitution. He has published widely in peered reviewed journals.
He is a high-volume surgeon for robotic prostatectomy and renal surgery. For robotic radical prostatectomy, his results for cancer margins, continence and potency are equivalent to the best-published data in the world.
Bijan Khoubehi is the lead clinician for urology at his NHS practice and has a busy urology practice performing robotic, laparoscopic and open surgery for urological cancer. Bijan prides himself on offering a completely honest, ethical and genuinely caring service, which is totally patient centred. He has had articles published about his work in national newspapers including Daily Mail and Mirror. He has published widely in peered reviewed journals. Bijan lives in London with his wife and two children.
Mr Paul Cathcart
MD FRCS(Urol)
Paul Cathcart has been a consultant urological surgeon since 2011. Initially appointed at University College London Hospital, Paul moved to Guys and St Thomas NHS Foundation Trust in 2015. He qualified from St George’s Hospital Medical School in 2000 before completing fellowships in uro-oncology and robotic surgery at The Royal Melbourne Hospital and the Peter MacCallum Cancer Centre in Melbourne, Australia.In addition to having a busy general urological practice, Paul is regarded as an expert both in prostate cancer diagnostics and the surgical management of prostate cancer. Paul performs in excess of 150 robotic prostatectomies each year and has a subspecialist interest in nerve-sparing prostate cancer surgery - where all the nerves around the prostate are preserved to maximise the likelihood of maintaining potency, as well as robotic prostate surgery for men with recurrent prostate cancer. In his NHS practice, Paul has set up a specialist multidisciplinary clinic for men with recurrent prostate cancer that receives referrals from all over the UK and has published his outcomes for men undergoing robotic prostatectomy for recurrent disease.
Paul is Clinical Co-ordinator for the National Prostate Cancer Audit and Chief Investigator for a number of clinical trials including the RAFT study which assesses the effectiveness and safety of salvage robotic prostate cancer surgery after focal therapy.
Paul also enjoys being involved in teaching and training of junior urologists. He is the London training programme director for specialist urology registrar training and is a national selector for the national training programme for urology. Paul is well published in the field of prostate cancer and lectures both nationally and internationally on this subject.
When Paul’s not at work he is usually found out running either training or competing!
Areas of Urological Practice
Prostate cancer diagnostics and management, robotic surgery including salvage robotic radical prostatectomy General urology
References
A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Year After Diagnosis of Prostate Cancer. Kinsella N, Beckmann K, Cahill D, Elhage O, PopertR, Cathcart P, Challacombe B, Brown C, Van Hemelrijck M. Eur Urol Oncol.2019 Jul;2(4):464-470. doi:10.1016/j.euo.2018.09.007. Epub 2018 Oct 11.
Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study. Parry MG, Sujenthiran A, Cowling TE, NossiterJ, Cathcart P, Clarke NW, Payne H, van der MeulenJ, Aggarwal A.J Clin Oncol. 2019 Jul 20;37(21):1828-1835. doi:10.1200/JCO.18.02237. Epub 2019 Jun 4.
Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, Emberton M, Sanchez-Salas R, Cathcart P. Eur Urol. 2019 Jul;76(1):27-30. doi: 10.1016/j.eururo.2019.03.007. Epub 2019 Mar 21.
Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: A national population-based study. Aggarwal AK, Sujenthiran A, Lewis D, Walker K, Cathcart P, Clarke N, Sullivan R, van der Meulen JH. Cancer. 2019 Jun 1;125(11):1898-1907. doi: 10.1002/cncr.31987. Epub2019 Feb 1.
Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England. Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Cathcart P, Clarke NW, Payne H, Aggarwal A, van der Meulen J. Int J Cancer. 2019 Jul 1;145(1):40-48. doi: 10.1002/ijc.32068. Epub 2019 Jan 17.
Initial outcomes of local anaesthetic freehand transperineal biopsies in the outpatient setting. Kum F, ElhageO, Maliyil J, Wong K, Faure Walker N, Kulkarni M, Namdarian B, Challacombe B, Cathcart P, Popert R. BJU Int. 2018 Nov 15. doi: 10.1111/bju.14620. [Epub ahead of print]
Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study. Sujenthiran A, Nossiter J, Parry M, Charman SC, Cathcart PJ, van der Meulen J, Clarke NW, Payne H, Aggarwal A.Radiother Oncol. 2018 Aug;128(2):357-363. doi: 10.1016/j.radonc.2018.04.032. Epub 2018 May 14.
Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England. Nossiter J, Sujenthiran A, Charman SC, Cathcart PJ, Aggarwal A, Payne H, Clarke NW, van der Meulen J. Br J Cancer. 2018 Feb 20;118(4):489-494. doi: 10.1038/bjc.2017.454. Epub 2018 Jan 18.
A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review. Faure Walker NA, Norris JM, Shah TT, Yap T, Cathcart P, Moore CM, Ahmed HU, Emberton M, Minhas S. Urol Oncol. 2018 Feb;36(2):67-76. doi: 10.1016/j.urolonc.2017.12.002. Epub 2017 Dec 23. Review.
King's Health Partners' Prostate Cancer Biobank (KHP PCaBB).Saifuddin SR, Devlies W, Santaolalla A, Cahill F, George G, Enting D, Rudman S, Cathcart P, Challacombe B, Dasgupta P, Galustian C, Chandra A, Chowdhury S, Gillett C, Van Hemelrijck M. BMC Cancer. 2017 Nov 22;17(1):784. doi: 10.1186/s12885-017-3773-8.
National cohort study comparing severe medium-term urinary complications after robot-assisted vs laparoscopic vs retropubic open radical prostatectomy. Sujenthiran A, Nossiter J, Parry M, Charman SC, Aggarwal A, Payne H, Dasgupta P, Clarke NW, van der Meulen J, Cathcart P. BJU Int. 2018 Mar;121(3):445-452. doi: 10.1111/bju.14054. Epub 2017 Nov 15..
National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.Sujenthiran A, Nossiter J, Charman SC, Parry M, Dasgupta P, van der Meulen J, Cathcart PJ, Clarke NW, Payne H, Aggarwal A. Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1253-1260. doi: 10.1016/j.ijrobp.2017.07.040. Epub 2017 Sep 1.
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.Linch M, Goh G, Hiley C, Shanmugabavan Y, McGranahan N, Rowan A, Wong YNS, King H, Furness A, Freeman A, Linares J, Akarca A, Herrero J, Rosenthal R, Harder N, Schmidt G, Wilson GA, Birkbak NJ, Mitter R, Dentro S, Cathcart P, Arya M, Johnston E, Scott R, Hung M, Emberton M, Attard G, Szallasi Z, Punwani S, Quezada SA, Marafioti T, Gerlinger M, Ahmed HU, Swanton C. Ann Oncol. 2017 Oct 1;28(10):2472-2480. doi: 10.1093/annonc/mdx355.
One Strategy Does Not Fit All: The Era of Personalised Medicine for the Treatment of Male Lower Urinary Tract Symptoms Is upon Us. Tregunna RL, Cathcart P, Bultitude MF. Eur Urol. 2017 Dec;72(6):998-999. doi: 10.1016/j.eururo.2017.07.042. Epub 2017 Aug 12. No abstract available.
Chilli-too hot to handle? Craddock C, Cathcart P, Stebbing J. Lancet Oncol. 2017 Aug;18(8):1005. doi: 10.1016/S1470-2045(17)30522-3. Epub 2017 Jul 26. No abstract available.
Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer. Crawley D, Chandra A, Loda M, Gillett C, Cathcart P, Challacombe B, Cook G, Cahill D, Santa Olalla A, Cahill F, George G, Rudman S, Van Hemelrijck M.BMC Cancer. 2017 Jul 21;17(1):494. doi: 10.1186/s12885-017-3458-3.
Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data.Sujenthiran A, Charman SC, Parry M, Nossiter J, Aggarwal A, Dasgupta P, Payne H, Clarke NW, Cathcart P, van der Meulen J. BJU Int. 2017 Aug;120(2):219-225. doi: 10.1111/bju.13770.Epub 2017 Feb 8.
18F-FECH PET/CT to Assess Clinically Significant Disease in Prostate Cancer: Correlation With Maximum and Total Cancer Core Length Obtained via MRI-Guided Template Mapping Biopsies. Haroon A, Ahmed HU, Cathcart P, Almuhaideb A, Kayani I, Dickson J, Kirkham A, Freeman A, Emberton M, Bomanji J. AJR Am J Roentgenol. 2016 Dec;207(6):1297-1306. Epub 2016 Sep 9.
Professor Mark Emberton
MD FRCS UrolMark Emberton is the Director of the Division of Surgery and Interventional Science at University College London. He is also UCL Partners'
Pathway Director for urological oncology for London Cancer - a provider network serving 4 million people that live north of the river Thames in London. He is the Honorary Clinical Director of the
Clinical Effectiveness Unit (CEU) at the Royal College of Surgeons of England. As
Professor of Interventional Oncology at UCL he leads a clinical innovation team that majors in experimental medicine by combining bio-engineering and nanotechnology with early phase trials in men with prostate cancer.His work encompasses the areas of diagnosis, risk stratification and therapy. He is also interested in the methodological aspects of clinical research, particularly on the use of alternatives to the randomised control trial in
surgery and design aspects of diagnostic studies. He is involved in guideline production and appraisal and is interested in the formulation of evidence based management policies.He is an active researcher, lectures widely and has published over 200 peer-reviewed articles in numerous scientific journals. He is a Trustee of the charity,
Prostate Action.
Pathway Director for urological oncology for London Cancer - a provider network serving 4 million people that live north of the river Thames in London. He is the Honorary Clinical Director of the
Clinical Effectiveness Unit (CEU) at the Royal College of Surgeons of England. As
Professor of Interventional Oncology at UCL he leads a clinical innovation team that majors in experimental medicine by combining bio-engineering and nanotechnology with early phase trials in men with prostate cancer.His work encompasses the areas of diagnosis, risk stratification and therapy. He is also interested in the methodological aspects of clinical research, particularly on the use of alternatives to the randomised control trial in
surgery and design aspects of diagnostic studies. He is involved in guideline production and appraisal and is interested in the formulation of evidence based management policies.He is an active researcher, lectures widely and has published over 200 peer-reviewed articles in numerous scientific journals. He is a Trustee of the charity,
Prostate Action.
Areas of Urological Practice
Detection, surveillance and minimally invasive treatment of prostate cancer
References
Mr Clément Orczyk
MD, PhD, FRCS, DESC (Urol), DES (Surg), MSc(R), MPH
orczyk@londonurologyspecialists.co.uk
Mr Clément Orczyk is a Clinical Academic, Consultant Urologist, and Clinical Lead of the Prostate Cancer Unit for diagnostics, active surveillance, and focal therapy at University College London Hospitals (UCLH). He also holds a tenure position as an Associate Professor of Urology at University College London (UCL).
Clément integrates innovation within his research and clinical practice, firmly believing in the interconnectedness of these fields to provide highest and above standard care patient care. His commitment to excellence in research and clinical care, particularly in the imaging and focal therapy of prostate cancer, has taken him from his native France to the United States, where he completed a fellowship at New York University in 2011, and subsequently to UCL. He has been a Consultant at UCLH since 2017.
Clément developed his expertise in prostate cancer during the early stages of a paradigm shift focused on detecting and treating the disease using the most advanced imaging techniques in conjunction with tissue analysis. He earned a PhD on this subject from a renowned French research center in collaboration with NYU. He authored the first publication establishing the necessary 3D margins for focal therapy to eradicate the whole cancer detected through imaging, thereby minimizing treatment side effects while maximizing the therapeutic outcomes of these innovative approaches.
In his routine practice, Clément delivers focal therapy to carefully selected patients using modalities such as focal High Intensity Focused Ultrasound (HIFU), focal cryotherapy, and Nanoknife electroporation. As one of the few clinicians globally proficient in multiple forms of ablation, he is uniquely positioned to select the most appropriate focal energy for optimal patient outcomes. He has performed over 700 focal therapy procedures using these techniques, in addition to those conducted within cutting-edge clinical trials involving new technologies.
Dedicated to individualized diagnosis, Clément adapts MRI and imaging findings to prostate biopsy, aiming to reduce their invasiveness while maximizing the information obtained for further disease stratification. He continues to advance his translational research program in prostate cancer detection, combining imaging, molecular biology, and more recently, Artificial Intelligence, with the goal of detecting only clinically significant disease for each patient. He is also exploring new approaches to cancer treatment.
Clément is a sought-after speaker at major international conferences, publishes in high-impact journals, and is committed to training both current and future generations of clinicians.
With his expertise in healthcare systems, innovation, and science, Clément seeks to contribute to Franco-British relations at a higher level as an appointee within the Young Leader Program of the Franco-British Council, supported by both the UK and French embassies and governments.
Mr Jeremy Ockrim
MD BSs (Hons), FRCS (Urol)
Jeremy Ockrim is an Associate Professor at University College London (UCL) and Consultant Urological Surgeon in Female and Reconstructive Surgery at University College London Hospital (UCLH), London.
Mr Ockrim trained in Glasgow before moving to Imperial College, London to complete his postgraduate thesis in 1999. He has an Honours Degree in Immunology; and his MD thesis on the utility of oestrogens in prostate cancer at the University of London. His fellowship was undertaken at the Royal Melbourne Hospital, Australia.
Mr Ockrim trained at the Institute of Urology, University College London Hospital (UCLH) and was appointed to his consultant post in 2008. UCLH offers tertiary expertise in Reconstructive Urology to Urologists and Urogynaecologists nationwide. He continues his academic and teaching links at UCL, and has written extensively on lower urinary tract dysfunction, male and female incontinence, detrusor overactivity, fistulae, diverticula and tape surgery and reconstructive (Mitrofanoff) surgery. His work has been referenced in national newspapers including Daily Mail and Mirror.
Mr Ockrim specialises in the treatment of bladder and prostate dysfunction, male and female incontinence and prolapse including colposuspension, TVT/TOT, complications of mesh implants, male sling, artificial urinary sphincter implantation, urinary fistulae and diverticula surgery, bladder augmentation / replacement and both continent and incontinent urinary diversion. He has particular interest in managing post prostatectomy incontinence in males, and bladder overactivity / pain syndromes.
He is the clinical lead for the post prostatectomy incontinence study (MASTER study) at UCLH, and comparison of sacral nerve neuromodulation versus Botox at UCLH. He is a member of the joint FFR-BSUG specialist unit at UCLH offering complex female incontinence treatment, management of complications of mesh surgery and treatment for urinary fistulae and urethral diverticulum. He is one of the first providers of sling surgery for male incontinence, and sacral nerve stimulation to manage urgency, incontinence and pain syndromes in the United Kingdom.
Mr Ockrim is a member of the British Association of Urological Surgeons (BAUS), European Association of Urology (EAU) and ESGURS and ESFFU guidelines, Royal College of Surgeons of Edinburgh, Royal Society of Medicine, British Medical Association and is assistant editor of the Central European Journal of Urology.
He has published over 70 papers and review articles.
Jeremy lives in London with his wife and three children.
Jeremy is a world expert in incontinence and prolapse and performance surgery without mesh
He is one of the first surgeons in the UK to offer non mesh
Also offering the following treatments:
- Non mesh and fixing mesh
- Avoiding mesh and mesh removal
Areas of Urological Practice
Male and female incontinence
TVT/TOT , autologous rectus fascial slings, Colposuspension,
Male sling, Artificial urinary sphincter implantation
Complications of incontinence surgery including mesh erosion/pain
Urinary fistulae and diverticula surgery
Prolapse repair
Anterior and posterior repair
Colposacropexy
Bladder reconstruction
Bladder augmentation
Bladder replacement and both continent and incontinent urinary diversion (Mitrofanoff diversion)
Bladder overactivity and pain syndromes
Medical therapy
Acupuncture
Botox
Sacral neuromodulation (nerve stimulators)
References
Bulking for stress urinary incontinence in men: A systematic review.mToia B, GrestyH, Pakzad M, Hamid R, OckrimJ, Greenwell T.Neurourol Urodyn. 2019 Jul 18. doi: 10.1002/nau.24102. [Epub ahead of print] Review.
The cost effectiveness of vaginal versus abdominal repair of vesicovaginal fistulae.Warner R, Beardmore-Gray A, Pakzad M, Hamid R, Ockrim J, Greenwell T. Int Urogynecol J. 2019 Jul 18. doi: 10.1007/s00192-019-04015-7.
Urethral diverticula in women are associated with increased urethra-sphincter complex volumes: A potential role for high-tone nonrelaxing sphincter in their etiology?Mukhtar BMB, Solomon E, Naaseri S, Aughwane P, Pakzad M, Hamid R, Ockrim JL, Greenwell TJ. Neurourol Urodyn. 2019 Jul 6. doi: 10.1002/nau.24080.
The incidence and outcomes of urodynamic stress urinary incontinence in female patients with urethral diverticulum. Barratt R, Malde S, Pakzad M, Hamid R, Ockrim J, Greenwell T. Neurourol Urodyn. 2019 Jul 3. doi: 10.1002/nau.24090.
Incidence, type and management of ureteric injury associated with vesicovaginal fistulas: Report of a series from a specialized center. Seth J, Kiosoglous A, Pakzad M, Hamid R, Shah J, Ockrim J, Greenwell T. Int J Urol. 2019 Jul;26(7):717-723. doi: 10.1111/iju.13965. Epub 2019 Jun 17.
Diagnosis and surgical outcomes of ectopic ureters in adults: A case series and literature review.Toia B, PakzadM, Hamid R, Wood D, Greenwell T, Ockrim J. NeurourolUrodyn. 2019 Aug;38(6):1745-1750. doi: 10.1002/nau.24054. Epub 2019 Jun 3.
Appendix or Ileum - Which is the Best Material for Mitrofanoff Channel Formation in Adults? O'Connor EM, Foley C, Taylor C, Malde S, Raja L, Wood DN, Hamid R, Ockrim JL, Greenwell TJ. J Urol. 2019 May 23:101097JU0000000000000356. doi: 10.1097/JU.0000000000000356.
Outcomes of reconstructive urinary tract surgery after pelvic radiotherapy. Toia B, Seth J, Ecclestone H, Pakzad M, Hamid R, Greenwell T, Ockrim J. Scand J Urol. 2019 Apr - Jun;53(2-3):156-160. doi: 10.1080/21681805.2019.1611631. Epub2019 May 15.
The autologous rectus fascia sheath sacrocolpopexy and sacrohysteropexy, a mesh free alternative in patients with recurrent uterine and vault prolapse: A contemporary series and literature review. Seth J, ToiaB, Ecclestone H, Pakzad M, Hamid R, Greenwell T, Ockrim J. Urol Ann. 2019 Apr-Jun;11(2):193-197. doi: 10.4103/UA.UA_85_18.
Correlation of MRI features of urethral diverticulum and pre- and post-operative stress urinary incontinence. Seth JH, Naaseri S, Solomon E, Pakzad M, Hamid R, Ockrim J, Greenwell TJ. Neurourol Urodyn. 2019 Jan;38(1):180-186. doi: 10.1002/nau.23820. Epub 2018 Nov 9.
Female Urology and Urogynecology: The Outcome of Patients Participating in Live Surgical Broadcasts.Itam S, PakzadM, Hamid R, Ockrim J, Vashisht A, Cutner A, Greenwell T. Female Pelvic Med Reconstr Surg. 2018 Sep 5. doi: 10.1097/SPV.0000000000000634. [Epubahead of print]
Does videourodynamicclassification depend on patient positioning in patients with stress urinary incontinence?Ecclestone H, Cashman S, Solomon E, Pakzad M, Hamid R, Greenwell T, Ockrim J. Neurourol Urodyn. 2018 Sep;37(7):2257-2262. doi: 10.1002/nau.23396. Epub 2018 Aug 22.
Predicting a successful outcome in sacral neuromodulation testing: Are urodynamic parameters prognostic? NobregaRP, Solomon E, Jenks J, Greenwell T, OckrimJ.NeurourolUrodyn. 2018 Mar;37(3):1007-1010. doi: 10.1002/nau.23383. Epub 2018 Mar 6.
The effects of recreational ketamine cystitis on urinary tract reconstruction - a surgical challenge. SihraN, Ockrim J, Wood D. BJU Int. 2018 Mar;121(3):458-465. doi: 10.1111/bju.14094. Epub 2018 Jan 11.
Preliminary report on the effect of urethral diverticulum magnetic resonance imaging configuration on the incidence of new onset urodynamic stress urinary incontinence following excision. MaldeS, Naaseri S, Kavia R, Pakzad M, Hamid R, Ockrim J, Greenwell TJ. Urol Ann. 2017 Oct-Dec;9(4):321-323. doi: 10.4103/UA.UA_13_17.
Female bladder outlet obstruction: Common symptoms masking an uncommon cause. Malde S, Solomon E, Spilotros M, Mukhtar B, Pakzad M, Hamid R, Ockrim J, Greenwell T. Low Urin Tract Symptoms. 2019 Jan;11(1):72-77. doi: 10.1111/luts.12196. Epub2017 Oct 9.
Radiotherapy is associated with reduced continence outcomes following implantation of the artificial urinary sphincter in men with post-radical prostatectomy incontinence.Guillaumier S, Solomon E, Jenks J, Pakzad M, Hamid R, Ockrim J, Shah J, Greenwell T.Urol Ann. 2017 Jul-Sep;9(3):253-256
Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity. Fontaine CL, Rudd I, Pakzad M, Hamid R, Ockrim JL, Greenwell TJ. Urol Ann. 2017 Jul-Sep;9(3):249-252
Eosinophilic granulomatosis with polyangiitis presenting with a vesicovaginal fistula. Famokunwa B, OckrimJ, Manson JJ.Rheumatology (Oxford). 2017 Jul 1;56(7):1080
Does the appearance of the urethral pressure profile trace correlate with the sphincter EMG findings in women with voiding dysfunction? SihraN, Malde S, Panicker J, Kightley R, Solomon E, Hamid R, Ockrim J, Greenwell TJ, Pakzad M.Neurourol Urodyn. 2017 Jul 5. doi: 10.1002/nau.23341
Does the Goh classification predict the outcome of vesico-vaginal fistula repair in the developed world? Beardmore-GrayA, Pakzad M, Hamid R, Ockrim J, Greenwell T. Int Urogynecol J. 2017 Jun;28(6):937-940. doi: 10.1007/s00192-016-3186-2.
Female urethral stricture: a contemporary series. SpilotrosM, Malde S, Solomon E, Grewal M, Mukhtar BM, Pakzad M, Hamid R, Ockrim JL, Greenwell TJ.World J Urol. 2017 Jun;35(6):991-995. doi: 10.1007/s00345-016-1947-7
Buccal mucosal graft urethroplasty in men-risk factors for recurrence and complications: a third referralcentre experience in anterior urethroplasty using buccal mucosal graft.Spilotros M, Sihra N,Malde S, Pakzad MH, Hamid R, Ockrim JL, Greenwell TJ. Transl Androl Urol. 2017 Jun;6(3):510-516
A systematic review of the literature on cystodistensionin bladder pain syndrome.OlsonLE, Dyer JE, Haq A, OckrimJ, Greenwell TJ.Int UrogynecolJ. 2017 May 26. doi: 10.1007/s00192-017-3355-y.
The correlation between retrograde leak point pressure and 24-hour pad weight. Solomon E, Kass-Iliyya A, MaldeS, Kirkham APS, Greenwell TJ, Ockrim JL.Neurourol Urodyn. 2017 Apr;36(4):1119-1123
The uses and outcomes of the Martius fat pad in female urology. Malde S, Spilotros M, Wilson A, Pakzad M, Hamid R, Ockrim J, Shah PJ, Greenwell T. World J Urol. 2017 Mar;35(3):473-478
Urethral diverticulectomy with Martius labial fat pad interposition improves symptom resolution and reduces recurrence. Malde S, Sihra N, Naaseri S, Spilotros M, Solomon E, Pakzad M, Hamid R, Ockrim JL, Greenwell TJ. BJU Int. 2017 Jan;119(1):158-163
A tertiary experience of ileal-ureter substitution: Contemporary indications and outcomes. Gomez-Gomez E, Malde S, Spilotros M, Shah PJ, J Greenwell T, Ockrim JL. Scand J Urol. 2016 Jun;50(3):192-9.
The impact of age, gender, and severity of overactive bladder wet on quality of life, productivity, treatment patterns and satisfaction Lloyd SM, Crawford G, McSkimming P, Grifi M, OckrimJLSubmitted BJUI March 2016 Évaluation de l'effet sur la qualité de vie du mirabégron dans le traitement de l'hyperactivité vésicale chez les patients neurologiques.Phe V, Mukhtar B, Couchman A, Grewal M, Hamid R, Ockrim J, Greenwell T, Panicker J,Pakzad M.Prog Urol. 2015 Nov;25(13):845-6.
The Long-Term Outcome of the Turner-Warwick Vaginal Obturator Shelf Urethral Repositioning Colposuspension Procedure for Urodynamically Proven Stress Urinary Incontinence. Greenwell T, Shah P, Hamid R, Shah PJ, Ockrim J.Urol Int. 2015 Nov;95(3):352-6.
The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK.Autiero SW, Hallas N, Betts CD, Ockrim JL.BJU Int. 2015 Dec;116(6):945-54.
Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment. Kass-Iliyya A, Julie Jenks J, Moore CM, Shah PJR, Hamid R, Greenwell TG and Ockrim JL Journal of Clinical Urology in press May 2014 Long-term efficacy of polydimethylsiloxane (Macroplastique®) injection for Mitrofanoff leakage after continent urinary diversion surgery. A Kass-Ilya A, TG Rashid TG, Citron I, Foley C, Hamid R, Greenwell TJ, PJR Shah PJR, OckrimJL. BJU Int. 2014 May 26. doi: 10.1111/bju.12817. [Epub ahead of print]
Stress urinary incontinence Kavia R, Rashid TG and Ockrim JL Journal of Clinical Urology, November 2013; vol. 6, 6: pp. 377-390.
Male incontinence: onabotulinum toxin A and sacral nerve stimulation. Rashid TG, Ockrim JL.Curr OpinUrol. 2013 Nov;23(6):545-51.
Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation: M. Martinson, S. MacDiarmid and E. Black J Urol 2013; 189: 210-216. Barnett G, Ockrim J.
Correlation of estimated and measured glomerular filtration rate in patients with interposed bowel in the urinary tract. Gurung PM, Greenwell TJ, Shah PJ, Ockrim JL. Scand J Urol Nephrol. 2011;45(4):290-5.
A tertiary experience of urethral diverticulectomy: diagnosis, imaging and surgical outcomes Ockrim JL, Shah PJR, Greenwell TJ. BJU Int. 2009 Jun;103(11):1550-4.
Snail expression is an independent predictor of tumorrecurrence in superficial bladder cancers. Bruyere F,Namdarian B, Corcoran NM, Pedersen J, Ockrim J, Voelzke BB, Mete U, Costello AJ, Hovens CM.UrolOncol. 2009;28(6):591-6
A tertiary experience of vesico-vaginal and urethro-vaginal fistula repair: factors predicting success Ockrim JL, Greenwell TJ, Wood DN, Foley CL, Shah PJR. BJU Int. 2009 Apr;103(8):1122-6.
Tension free transvaginal (TVT) and transobturator(TOT) tape procedures in women with multiple failed incontinence procedures or complex urogynaecological intervention Ockrim JL, Shah PJR, Greenwell TJ. BJMSU 2008 Sept;1(2):67-74
Considering the long-term impact of androgen deprivation therapy for prostate cancer: is it timely to reconsider options? Ockrim JL and Abel PD BMJ Editorial 2008;337:a1361
Aurora Kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint. BruyereF, Corcoran NM, Berdjis N, NamdarianB, Pedersen J, Ockrim JL, VoelzkeBB, Costello AJ, Hovens CM. BJU Int. 2008 Jul;102(2):247-52. Epub 2008 Jul 1.
Therapy Insight: parenteral estrogen treatment for prostate cancer-a new dawn for an old therapy. OckrimJL, Lalani E, Abel PD Nat Clin Pract Oncol. 2006 Oct;3(10):552-63. Review.
Changes in vascular flow during transdermal estradioltherapy for prostate cancer: the dichotomy of early versus delayed effect? Ockrim JL, Lalani E, Aslam M, Stansfield H, Kakkar AK, Abel PD. BJU Int. 2006 Mar;97(3):498-504.
Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism Ockrim JL, Lalani E, Kakkar AK, Abel PD. J Urol. 2005 Aug;174(2):527-33
Variability of detrusor overactivity on repeated filling cystometryin men with urge symptoms: comparison with spinal cord injury patients. Ockrim JL, Laniado ME, Khoubehi B, Renzetti R, Finazzi Agrò E, Carter S and Tubaro A. BJU Int. 2005 Mar;95(4):587-90.
Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer OckrimJL, Lalani E, Banks LM, Svensson WE, Blomley MJ, Patel S, Laniado ME, Carter S and Abel PD J Urol. 2004 Dec;172(6, Part 1 of 2):2203-2207.
Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms. Laniado ME, Ockrim JL, Marronaro A, Tubaro A, Carter S. BJU Int. 2004 Dec;94(9):1283-6.
Transdermal estradiol therapy for advanced prostate cancer--forward to the past? Ockrim JL, LalaniEN, Laniado ME, Carter SS, Abel PD.JUrol. 2003 May;169(5):1735-7.
A probability based system for combining simple office parameters as a predictor of bladder outflow obstruction. Ockrim JL, LaniadoME, Patel A, Tubaro A, St Clair Carter S. J Urol. 2001
Mr Richard Nobrega
MBBS BSc (Hons) FRCS(Urol) RCPathME
nobrega@londonurologyspecialists.co.uk
Mr Nobrega is Clinical Lead for Neuro-Urology at the Royal National Orthopaedic Hospital (RNOH), one of the UK’s largest specialist commissioned spinal injury units and Consultant Urological Surgeon at University College Hospital London where he is Co-Chair for Female, Reconstructive and Adolescent Urology services across North Central London.
He specialises in the treatment of complex male and female voiding dysfunction and incontinence, and expert in reconstruction of the urinary tract in spinal injury patients with neurogenic bladder.
He is also part of a specialised team providing cancer survivorship for both men and women who suffer with incontinence after cancer surgery and radiotherapy.
Mr Nobrega trained at University College London, before moving to Oxford University teaching Hospitals to complete his specialist training. He has an honours degree in physiology. His clinical fellowship was undertaken within the Female, Reconstructive and Adolescent (FRA) unit at University College London Hospital where he was appointed a substantive consultant in 2022. The FRA Unit offers tertiary expertise in male and female reconstructive urology to urologists and urogynaecologists nationwide.
Mr Nobrega continues his academic and teaching links with Oxford University and University College London, and has presented and published nationally and internationally on spinal cord injury and neurogenic bladder, lower urinary tract dysfunction, urodynamics, anti-incontinence surgery and reconstructive urology.
His practice specialises in the treatment of neurogenic and non-neurogenic bladder dysfunction, male and female incontinence including colposuspension, autologous fascial sling, artificial urinary sphincter implantation, urinary fistulae and diverticula surgery, prolapse repair, bladder augmentation, bladder replacement and both continent and incontinent urinary diversion. He has particular interest in the holistic management and life long care of spinal cord injury patients with neurogenic bladder including dysreflexia, urodynamics, stones, botox, neuromodulation and SARSI.
Mr Nobrega is a member of the British Association of Urological Surgeons (BAUS), European Association of Urology, American Urological Association, Royal College of Surgeons of England, Royal Society of Medicine and British Medical Association.
Mr Marios Hadjipavlou
FRCS (Urol) MRCS, MBBS BSchadjipavlou@londonurologyspecialists.co.uk
Marios Hadjipavlou is a Consultant Urological Surgeon at Guy's and St Thomas' NHS Foundation Trust, an Honorary Consultant at Lewisham & Greenwich NHS Trust as well as an Honorary Senior Clinical Lecturer at King’s College London School of Medicine.
He qualified from King’s College London School of Medicine and completed his surgical and urological higher specialist training at Guy’s Hospital, St George’s Hospital and other reputable urology units in London and the South East of England.
He has a specialist interest in benign prostate hyperplasia (BPH), Holmium Laser Enucleation of Prostate (HoLEP) for treatment of very enlarged prostates, novel minimally invasive BPH treatments, precision prostate cancer diagnostics, endourology & stone disease management. He also has an interest in diagnostic urology and performs a wide range of general urological procedures.
He served as an expert advisor for the National Institute for Health and Care Excellence (NICE) in the development of guidance for several new medical technologies for treatment of benign prostatic hyperplasia. He is actively involved in clinical research and trials on benign prostate disease, HoLEP and prostate cancer.
He is the Medical Education Faculty Group Lead for urology trainees at Guy’s Hospital and he regularly delivers undergraduate and postgraduate training. He has a strong academic interest with over 30 publications, 6 book chapters and over 60 national & international presentations including over 12 prizes from reputable organizations including the European Association of Urology, the British Association of Urological Surgeons and the Royal Society of Medicine.
Area of Urological Practice
Benign prostatic hyperplasia, benign prostatic disease, holmium laser enucleation of the prostate, prostate cancer, urinary tract stone disease, haematuria, transurethral resection of the prostate.
References
Safety of hot and cold site admissions within a high volume urology department in the United Kingdom at the peak of the COVID-19 pandemic.
Stroman L, et al [including Hadjipavlou M] BJUI Compass. 2021 Jan. PMID 33821256
Continuity of cancer care: the surgical experience of two large cancer hubs in London and Milan.
Monroy-Iglesias MJ, et al [including Hadjipavlou M] Cancers (Basel). 2021 Apr. PMID 33808375
Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
Hadjipavlou M, Eragat M, Kenny C, Pantelidou M, Mulhem W, Wood C, Dall’Antonia M, Hammadeh MY. Eur Urol Focus 2020 Jan15;6(1):95-101. PMID 31928632
Vaccines for the prevention of recurrent urinary tract infections: A systematic review.
Aziminia N, Hadjipavlou M, Philippou Y, Pandian SS, Malde S, Hammadeh MY. BJU Int. 2019 May;123(5):753-768. PMID 30378242
Testicular Rupture or Testicular Fracture? A Case Report and Literature Review.
Addas F, Yan S, Hadjipavlou M, Gonsalves M, Sabbagh SCase Rep Urol. 2018 Nov 14;2018:1323780. PMID 30538883
Villous adenoma of the urachal remnant: A diagnostic conundrum. Rare Tumors.
Ugwuoke O, Hadjipavlou M, Pinto T, Arora A, Hammadeh MY. 2018 Jun 5;10:2036361318779514. PMID 29899888
Managing penetrating renal trauma: experience from two UK major trauma centres.
Hadjipavlou M, Grouse E, Gray R, Sri D, Huang D, Brown C, Sharma D. BJU Int. 2018 Jun;121(6):928-934. PMID 29438587
Radiation exposure during ureterorenoscopy and laser lithotripsy: an analysis of stone characteristics.
Hadjipavlou M, Lam V, Seth J, Anjum F, Sriprasad S. Urol Int. 2018 Feb 13; 100(2):184-188. PMID 29439267
Spontaneous rupture of a renal artery pseudoaneurysm with no precipitating risk factor.
Hadjipavlou M, Abbaraju J, Serafimov V, Madaan S. JRSM Open. 2018 Apr 18;9(4):2054270418758568. PMID 29707224
Traumatic Scrotal and Testicular Injuries. For “A Clinical Guide to Urologic Emergencies”
Hadjipavlou M, Sharma DM. (2020) edited by Wessells H; Wiley, USA
Bladder & Prostate Cancer For “Plants that Fight Cancer 2nd ed”
Khoo C, Philippou Y, Hadjipavlou M, Rane A. (2019) edited by Kintzios S, Barberaki M, Flampouri E; Taylor&Francis, USA
History and Evolution of Laparo-endoscopic Single-site Surgery (LESS). For “Atlas of Laparoscopic and Robotic Single Site Surgery”
Hadjipavlou M, Khan S, Rane A. (2017) edited by Kaouk JH, Stein RJ, Haber GP; Springer, USA.
Our Location
King Edward VII’s Medical Centre, 54 Beaumont Street, London W1G 6DW
If you would like to make an appointment please get in touch
+44 (0)30 0302 0202 or email info@londonurologyspecialists.co.uk